Literature DB >> 10069219

Familial Mediterranean fever--renal involvement by diseases other than amyloid.

M Tekin1, F Yalçinkaya, N Tümer, N Cakar, H Koçak, N Ozkaya, H Gençgönül.   

Abstract

BACKGROUND: In patients with familial Mediterranean fever (FMF) renal involvement is usually in the form of AA amyloidosis. There is increasing evidence that renal involvement may be due to diseases other than amyloid as well.
METHODS: Amongst 302 children with FMF we observed and followed 28 with typical clinical and laboratory features of vasculitis. The diagnosis of FMF was established according to the Tel Hashomer criteria.
RESULTS: Polyarteritis nodosa, protracted febrile attacks and Henoch-Schönlein purpura were diagnosed in 4, 13, and 11 patients, respectively. The presentation was often difficult to distinguish from FMF attacks, but protracted febrile attacks lasting several weeks, hypertension, thrombocytosis, and dramatic responses to corticosteroid therapy that were observed in many cases were different from what is observed in classical FMF.
CONCLUSIONS: We suggest that FMF, perhaps as a consequence of impaired control of inflammatory responses, predisposes to vasculitis with renal involvement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069219     DOI: 10.1093/ndt/14.2.475

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  17 in total

1.  Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report.

Authors:  Erynn M Boyer; Martin Turman; Kathleen M O'Neil
Journal:  Pediatr Rheumatol Online J       Date:  2011-08-11       Impact factor: 3.054

2.  Acute renal failure in a patient with familial Mediterranean fever.

Authors:  Z Birsin Ozçakar; Selçuk Yüksel; Arzu Ensari; Mesiha Ekim; Fatoş Yalçinkaya
Journal:  Rheumatol Int       Date:  2006-09-02       Impact factor: 2.631

3.  Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first case report.

Authors:  Eray Eroglu; Ismail Kocyigit; Ozturk Ates; Aydin Unal; Murat Hayri Sipahioglu; Hulya Akgun; Bulent Tokgoz; Oktay Oymak
Journal:  Int Urol Nephrol       Date:  2012-01-20       Impact factor: 2.370

Review 4.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

5.  Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever.

Authors:  Nuray Aktay Ayaz; Ayşe Tanatar; Şerife Gül Karadağ; Mustafa Çakan; Gonca Keskindemirci; Hafize Emine Sönmez
Journal:  Rheumatol Int       Date:  2020-04-28       Impact factor: 2.631

6.  IgA nephropathy in an Italian child with familial Mediterranean fever.

Authors:  Donato Rigante; Gilda Federico; Pietro Ferrara; Nicola Maggiano; Laura Avallone; Anna Lisa Pugliese; Achille Stabile
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

7.  Native kidney biopsies in Armenian and Swiss children: high prevalence of amyloidosis in Yerevan and of IgA nephropathy in Zurich.

Authors:  Guido F Laube; Ashot Sarkissian; Helen Nazaryan; Giuseppina Spartà; Armen Sanamyan; Ara Babloyan; Ernst Leumann; Ariana Gaspert
Journal:  Virchows Arch       Date:  2014-11-08       Impact factor: 4.064

8.  Polyarteritis nodosa and Henoch-Schönlein purpura nephritis in a child with familial Mediterranean fever: a case report.

Authors:  Ilknur Girisgen; Ferah Sonmez; Kutsi Koseoglu; Seda Erisen; Dilek Yilmaz
Journal:  Rheumatol Int       Date:  2011-01-23       Impact factor: 2.631

Review 9.  Familial Mediterranean fever and glomerulonephritis and review of the literature.

Authors:  Tekin Akpolat; Ilkser Akpolat; Filiz Karagoz; Engin Yilmaz; Bedri Kandemir; Seza Ozen
Journal:  Rheumatol Int       Date:  2003-06-27       Impact factor: 2.631

10.  Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.

Authors:  Z Birsin Özçakar; Semanur Özdel; Songül Yılmaz; E Didem Kurt-Şükür; Mesiha Ekim; Fatoş Yalçınkaya
Journal:  Clin Rheumatol       Date:  2014-09-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.